Faron, etusivu

releases and publications

Bexmarilimab Efficacy and Safety in MATINS Trial

Bexmarilimab KOL Event

Poster Presentations at AACR 2023

BEXMAB study update

Regulatory

Faron at Canaccord Oncology Virtual Conference

Appointment of Chief Financial Officer

Regulatory

Board Change

Regulatory

Results of AGM

Regulatory

Positive FDA Feedback to Progress Bexmarilimab

Regulatory

Notice of Faron Pharmaceuticals Ltd’s AGM

Regulatory
PreviousNext
Back to top